Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 8953 - 8960 of 12004 results

EU Parliament Committee calls on the Commission for immediate action on US data transfers

October 14, 2015| Blog| Viewpoint

Something is Rotten at the Pork Roll Company ... and it’s not the Pork Rolls: Flatulent Employee (and his Wife) Bring Claims for Disability Discrimination

October 13, 2015| Blog| Viewpoint

The Affordable Care Act’s Reporting Requirements for Carriers and Employers (Part 13 of 24): Coding Form 1095-C, Part II for Short- and Long-Term Disability Benefits

October 13, 2015| Blog| Viewpoint

FDA Releases First Wholesaler and 3PL Facility Licensure Data to the Public

October 12, 2015| Blog| Viewpoint

ACC Annual Conference Panel: Dual-Track M&A and IPO Pathways

October 12, 2015| Blog| Viewpoint

A WARNing to Directors and Officers — Failure to give proper WARN Act notice may breach your fiduciary duty

October 9, 2015| Blog| Viewpoint

Federal Circuit Holds That It Lacks Jurisdiction To Review PTAB’s § 315 Time-Bar Determination

October 9, 2015| Blog| Viewpoint

A WARNing to Directors and Officers — Failure to Give Proper WARN Act Notice May Breach Your Fiduciary Duty

October 9, 2015| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases